Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alanna A Morris
Javed Butler

Circulation

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Circulation|April 1, 2022
Updated Heart Failure Guidelines: Time for a RefreshAlanna A Morris, Javed Butler
Circulation|June 14, 2021
Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Racial Differences and a Potential for Reducing DisparitiesAlanna A Morris, Jeffrey M Testani, Javed Butler
Circulation|October 18, 2021
Premature Cardiovascular Mortality in the United States: Who Will Protect the Most Vulnerable Among Us?Apoorva Gangavelli, Alanna A Morris
Circulation|November 27, 2023
Expanding the Definition of Worsening Heart Failure and Recognizing the Importance of Outpatient Escalation of Oral DiureticsStephen J Greene, Javed Butler
Circulation|October 18, 2017
The Ethics of Conducting Clinical Trials With Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Is Placebo Assignment Justified in Patients With Comorbid Diabetes Mellitus and Heart Failure?Javed Butler, Stefan D Anker
Circulation|January 8, 2019
Primary Prevention of Heart Failure in Patients With Type 2 Diabetes MellitusStephen J Greene, Javed Butler
Circulation|March 7, 2018
Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus: Mechanistic Links, Clinical Data, and Future DirectionsShilpa Vijayakumar, Muthiah Vaduganathan, Javed Butler
Circulation|November 16, 2020
Benefit-Risk Tradeoffs in Assessment of New Drugs and DevicesSanjay Kaul, Norman Stockbridge, Javed Butler
Circulation|May 13, 2024
Win Ratio: A Seductive But Potentially Misleading Method for Evaluating Evidence from Clinical TrialsJaved Butler, Norman Stockbridge, Milton Packer
Circulation|September 21, 2020
Victims of Success in FailureCarolyn S P Lam, Javed Butler
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Circulation|April 1, 2022
Updated Heart Failure Guidelines: Time for a RefreshAlanna A Morris, Javed Butler
Circulation|June 14, 2021
Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Racial Differences and a Potential for Reducing DisparitiesAlanna A Morris, Jeffrey M Testani, Javed Butler
Circulation|October 18, 2021
Premature Cardiovascular Mortality in the United States: Who Will Protect the Most Vulnerable Among Us?Apoorva Gangavelli, Alanna A Morris
Circulation|November 27, 2023
Expanding the Definition of Worsening Heart Failure and Recognizing the Importance of Outpatient Escalation of Oral DiureticsStephen J Greene, Javed Butler
Circulation|October 18, 2017
The Ethics of Conducting Clinical Trials With Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Is Placebo Assignment Justified in Patients With Comorbid Diabetes Mellitus and Heart Failure?Javed Butler, Stefan D Anker
Circulation|January 8, 2019
Primary Prevention of Heart Failure in Patients With Type 2 Diabetes MellitusStephen J Greene, Javed Butler
Circulation|March 7, 2018
Glucose-Lowering Therapies and Heart Failure in Type 2 Diabetes Mellitus: Mechanistic Links, Clinical Data, and Future DirectionsShilpa Vijayakumar, Muthiah Vaduganathan, Javed Butler
Circulation|November 16, 2020
Benefit-Risk Tradeoffs in Assessment of New Drugs and DevicesSanjay Kaul, Norman Stockbridge, Javed Butler
Circulation|May 13, 2024
Win Ratio: A Seductive But Potentially Misleading Method for Evaluating Evidence from Clinical TrialsJaved Butler, Norman Stockbridge, Milton Packer
Circulation|September 21, 2020
Victims of Success in FailureCarolyn S P Lam, Javed Butler
Pageof 8